Radiotherapy of soft tissue sarcoma

Phase 2

Recruiting

• Conditions: Malignant neoplasm of connective and soft tissue.; Malignant neoplasm of connective and soft tissue, unspecified; C49.9

• Registration Number: IRCT20180919041070N3
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Pathologically confirmed localized soft tissue sarcoma of the extremity
Age = 18 years
Performance status < 2

Exclusion Criteria

Distant metastasis
Pregnancy
History of connective tissue diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival. Timepoint: 12 months after treatment. Method of measurement: visiting the patient.;Recurrence. Timepoint: 1, 6, and 12 months after treatment. Method of measurement: Taking history and physical exam.;Limb function. Timepoint: 1, 6, and 12 months after treatment. Method of measurement: physical exam.

Secondary Outcome Measures

Name	Time	Method
Complications. Timepoint: 1, 6, and 12 months after treatment. Method of measurement: Physical exam.